Human NACHT, LRR, and PYD domain–containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase-Reference-Cited by-同舟云学术

Human NACHT, LRR, and PYD domain–containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase

Published:2017-10 Issue:4 Volume:140 Page:1054-1067.e10
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Liu Xiao,Pichulik Tica,Wolz Olaf-Oliver,Dang Truong-Minh,Stutz Andrea,Dillen Carly,Delmiro Garcia Magno,Kraus Helene,Dickhöfer Sabine,Daiber Ellen,Münzenmayer Lisa,Wahl Silke,Rieber Nikolaus,Kümmerle-Deschner Jasmin,Yazdi Amir,Franz-Wachtel Mirita,Macek Boris,Radsak Markus,Vogel Sebastian,Schulte Berit,Walz Juliane Sarah,Hartl Dominik,Latz Eicke,Stilgenbauer Stephan,Grimbacher Bodo,Miller Lloyd,Brunner Cornelia,Wolz Christiane,Weber Alexander N.R.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference59 articles.

1. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity;Kawai;Immunity,2011

2. NLRP3 and IL-1beta in macrophages as critical regulators of metabolic diseases;McGettrick;Diabetes Obes Metab,2013

3. Sterile inflammation: sensing and reacting to damage;Chen;Nat Rev Immunol,2010

4. The inflammasomes and autoinflammatory syndromes;Broderick;Annu Rev Pathol,2015

5. Inflammasome-mediated production of IL-1beta is required for neutrophil recruitment against Staphylococcus aureus in vivo;Miller;J Immunol,2007

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bruton’s tyrosine kinase (BTK) inhibitors alter blood glucose and insulin in obese mice but reduce inflammation independent of BTK;American Journal of Physiology-Endocrinology and Metabolism;2024-09-01

2. Measuring Interactions Between Proteins and Small Molecules or Nucleic Acids;Current Protocols;2024-07

3. A Dual‐Function CD47‐Targeting Nano‐Drug Delivery System Used to Regulate Immune and Anti‐Inflammatory Activities in the Treatment of Atherosclerosis;Advanced Healthcare Materials;2024-05-31

4. Schnitzler Syndrome: Insights into Its Pathogenesis, Clinical Manifestations, and Current Management;Biomolecules;2024-05-31

5. New Insights on NLRP3 Inflammasome: Mechanisms of Activation, Inhibition, and Epigenetic Regulation;Journal of Neuroimmune Pharmacology;2024-02-29